FDA recall D-0150-2023

Akorn, Inc. · Class II · drug

Product

Olopatadine HCl Ophthalmic Solution, USP 0.1%, 5 mL (0.17 FL OZ) per bottle, Antihistamine and Redness Reliever, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC: 51407-499-05

Reason for recall

CGMP Deviations:

Distribution

Nationwide in the USA

Key facts

Status: Ongoing
Initiation date: 2022-10-13
Report date: 2023-01-25
Voluntary/Mandated: Voluntary: Firm initiated
Location: Gurnee, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0150-2023